PR Newswire

Advertisement

Send your own press release

RSS PRNewswire

  • I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs Januari 28, 2022
    SHANGHAI and GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the signing of a partnership agreement with the Hangzhou Qiantang New Area in China to manufacture its innovative drugs locally and accelerate its transition to commercialization. This strategic partnership […]
  • Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling Januari 28, 2022
    MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels) setting in motion a crucial trial in the Native Coronary Vessel Treatment domain. TRANSFORM II RCT - […]
  • Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease Januari 28, 2022
    Study demonstrates reduction of α-synuclein aggregation and preservation of neurons MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple System Atrophy (MSA) were published in the Journal […]
  • "Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches Januari 28, 2022
    TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day on January 30. The international campaign includes awareness-raising events and outreach to governments, and is being publicized via newspapers, television, radio and […]
  • Getinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow" Januari 28, 2022
    GOTHENBURG, Sweden, Jan. 28, 2022 /PRNewswire/ -- "The organic order intake increased 6.4% in the fourth quarter following growth in all business areas and regions", says Mattias Perjos, President & CEO at Getinge. "Excluding currency effects, our order bookings are more than 20% larger compared with one year ago." As expected, Getinge's net sales declined […]
  • Discover the hidden treasures of Japan: a spectacular cultural legacy, in unity with nature Januari 28, 2022
    TOKYO, Jan. 28, 2022 /PRNewswire/ -- Last November, the Agency for Cultural Affairs, in cooperation with the Japan National Tourism Organization, revealed additional special content featuring exclusive destinations for its Japan Heritage website. The content helps provide a more relaxed travel experience; soaking in the local atmosphere and taking a deep dive into Japan Heritage's […]
  • ESTA launches "ULTRABloom" Foam Hand Sanitiser, that is alcohol free with natural moisturising floral botanicals Januari 28, 2022
    SINGAPORE, Jan. 28, 2022 /PRNewswire/ -- ESTA Technology proudly launches the floral based ESTA ULTRABloom. Made purely from botanical floral sources, with a subtly sweet fragrance, ESTA ULTRABloom is the first of its range under ESTA Technology Pte Ltd. It is alcohol free, thus suitable for sensitive skin and is also kid friendly. Non-alcohol sanitisers are moisturizing and good […]
  • Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022 Januari 28, 2022
    DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th, a leading laboratory and flagship exhibition and conference that brings together global medical communities to display the best laboratory innovation and […]
  • CGTN: Celebrating Lunar New Year, China embarks on new journey Januari 28, 2022
    BEIJING, Jan. 28, 2022 /PRNewswire/ -- The Chinese New Year, which is also called the Spring Festival, is the most important Chinese festival centering on family reunions. It's like a combination of Christmas and New Year in the West.   The Spring Festival falls on February 1 this year. From mouthwatering food to new clothes, decorations […]
  • ASIA'S LARGEST, MOST ACTION-PACKED SHIP, SPECTRUM OF THE SEAS, TO ARRIVE EARLY IN SINGAPORE Januari 28, 2022
    International Guests can Sail on Royal Caribbean International's Popular Ocean Getaways as soon as April 2022 SINGAPORE, Jan. 28, 2022 /PRNewswire/ -- Holidaymakers can now pack their bags from April 11, 2022 for the ultimate adventure on board Royal Caribbean International's Spectrum of the Seas, Asia's largest, newest and most innovative ship, for spectacular 3- […]
  • ASIA'S LARGEST, MOST ACTION-PACKED SHIP, SPECTRUM OF THE SEAS, TO ARRIVE EARLY IN SINGAPORE Januari 28, 2022
    International Guests can Sail on Royal Caribbean International's Popular Ocean Getaways as soon as April 2022 SINGAPORE, Jan. 28, 2022 /PRNewswire/ -- Holidaymakers can now pack their bags from April 11, 2022 for the ultimate adventure on board Royal Caribbean International's Spectrum of the Seas, Asia's largest, newest and most innovative ship, for spectacular 3- […]
  • Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis Januari 28, 2022
    Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to be accretive to earnings in 2022 and thereafter, fully capitalizing on the high growth potential of Samsung Bioepis Expected to accelerate growth in biosimilars and novel therapeutics R&D Purchase to be […]
  • The Royal Mint unveils a one-of-a-kind 8kg gold coin to celebrate Chinese New Year Januari 28, 2022
    The Royal Mint has unveiled an 8kg gold proof coin to celebrate the Year of the Tiger as part of its 'Masterworks' range and popular Shēngxiào Collection. The 8kg gold proof coin is the largest coin ever produced as part of The Royal Mint's Shēngxiào Collection. A team of master craftspeople produced the solid gold coin, […]
  • Amorepacific Develops the World's First Tactile Sensor That Measures Skin Sensations Januari 28, 2022
    Findings jointly made with UNIST published on a global scientific journal ACS Nano Digitalization of human skin sensations expected to spark innovation in the beauty industry SEOUL, South Korea, Jan. 28, 2022 /PRNewswire/ -- Amorepacific developed the world's first intelligent tactile sensor that is capable of measuring skin sensations. This new sensor will enable the […]
  • HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate Januari 27, 2022
    Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou (CN) HaemaLogiX will leverage Lonza's regulatory expertise, global manufacturing footprint, and extensive experience in manufacturing monoclonal antibodies BASEL, Switzerland and SYDNEY, Jan. 28, 2022 /PRNewswire/ -- HaemaLogiX Ltd (HaemaLogiX), the clinical-stage biotechnology […]
  • Enable Injections Announces $215 Million Financing Januari 27, 2022
    New financing provides significant financial flexibility to propel growth efforts, benefitting patients, providers, and pharma partners worldwide. CINCINNATI, Jan. 27, 2022 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a company developing and manufacturing the enFuse® platform of investigational wearable drug delivery systems, is pleased to announce $215 million in Series C financing. Magnetar Capital ("Magnetar") led the financing […]
  • CGTN: CMG Forum: Together for a high-tech Winter Olympics Januari 27, 2022
    BEIJING, Jan. 27, 2022 /PRNewswire/ -- China Media Group (CMG), the country's major broadcaster, is joining hands with media partners worldwide to deliver the real-time pulse of the Olympic Winter Games Beijing 2022 to global spectators with cutting-edge technologies. CMG Forum: Together for a high-tech Winter Olympics CMG, a rights-holding broadcaster of the Winter Olympics, […]
  • Ractigen Therapeutics closes an additional $30 million in Series A+ funding to push development of its RNAa platform Januari 27, 2022
    NANTONG, China, Jan. 27, 2022 /PRNewswire/ -- Ractigen Therapeutics, a pioneer of the RNAa technology, today announced the closing of a Series A+ financing round totaling $30 million led by SDIC Venture Capital with participation from Eisai Co., Ltd., LC Ventures, CSSD Capital, and Xianghe Capital. This latest round comes on the heels of a […]
  • FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion Januari 27, 2022
    Breakthrough Therapy Designation further demonstrates excellent clinical profile of DZD9008 (Sunvozertinib) SHANGHAI, Jan. 27, 2022 /PRNewswire/ -- Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer […]
  • Brii Bio Appoints Karen D. Neuendorff as Chief People Officer and Head of Human Resources Januari 27, 2022
    Senior hire strengthens Brii Bio's leadership team and aligns with Company's mission to tackle the world's largest public health issues affecting everyday people DURHAM, N.C. and BEIJING, Jan. 27, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and […]

RSS PRNewswire

  • Universiti Teknologi Malaysia Solar Energy Technology Transfer Projects Prospering Communities Januari 28, 2022
    JOHOR BAHRU, Malaysia, Jan. 28, 2022  /PRNewswire/ -- Recently, UTM's School of Electrical Engineering researchers have installed solar panels on fishing boats to replace the use of diesel mainly for environmental sustainability purpose. Universiti Teknologi Malaysia (UTM) is a research university that is well-known for its continuous solar technology initiatives for the benefit of the […]
  • I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs Januari 28, 2022
    SHANGHAI and GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the signing of a partnership agreement with the Hangzhou Qiantang New Area in China to manufacture its innovative drugs locally and accelerate its transition to commercialization. This strategic partnership […]
  • China Matters presents 'Zhongshan Efficiency' Januari 28, 2022
    BEIJING, Jan. 28, 2022 /PRNewswire/ -- What is 'Zhongshan Efficiency'? In Zhongshan City of Guangdong Province, it takes only five minutes to change the legal representative on a business license. It takes only 10 minutes for the government to solve problems for enterprises on a breakfast meeting. It takes only 15 minutes for an enterprise […]
  • Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling Januari 28, 2022
    MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels) setting in motion a crucial trial in the Native Coronary Vessel Treatment domain. TRANSFORM II RCT - […]
  • Skillful Craftsman to Acquire Controlling Interest of Major Flexible Staffing Platform in Jiangsu Province to Expand Online Business Presence Domestically Januari 28, 2022
    WUXI, China, Jan. 28, 2022 /PRNewswire/ -- Skillful Craftsman Education Technology Ltd. (the "Company") (NASDAQ: EDTK), an education technology company providing interactive online learning services, announced that on January 28, 2022 the Company entered into an equity transfer agreement (the "Agreement") with certain shareholders of Wuxi Talent Home Information Technology Co., Ltd. ("WTH"), one of […]
  • First High-School Education Group's Voluntary Update on Operation Januari 28, 2022
    BEIJING, Jan. 28, 2022 /PRNewswire/ -- First High-School Education Group Co., Ltd. ("First High-School Education Group" or the "Company") (NYSE: FHS), an education service provider primarily focusing on high schools in Western China, today announced its voluntary update on Company's business operations. The Company's board of directors is aware of the recent unusual fluctuations in the […]
  • Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease Januari 28, 2022
    Study demonstrates reduction of α-synuclein aggregation and preservation of neurons MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple System Atrophy (MSA) were published in the Journal […]
  • Euroclear group reports another record year and delivery of financial targets two years ahead of plan Januari 28, 2022
    Results for the Year Ending 31 December 2021 BRUSSELS, Jan. 28, 2022 /PRNewswire/ -- Highlights                   Full year revenue growth stronger than expected  Operating income up +9% year-on-year Business income up +15% year-on-year,  with operating metrics growing strongly - Assets under custody up +15% year-on-year to EUR 37.6 trillion- Transactions volumes up +7% year-on-year to 295 million […]
  • Autoliv: Financial Report October - December 2021 Januari 28, 2022
    STOCKHOLM, Jan. 28, 2022 /PRNewswire/ --  (NYSE: ALV) and (SSE: ALIV.sdb)  Q4 2021: Solid profitability and cash flow Financial highlights Q4 2021 $2,119m net sales  16% organic sales decline* 8.2% operating margin  8.3% adjusted operating margin*  $1.31 EPS - a decrease of $0.84 $1.30 adjusted EPS* - a decrease of $0.89 Full year 2022 indications Around 20% organic sales growth  Around 3% negative […]
  • Huawei Strengthens Support for ASEAN Economic Community's Industry 4.0 Roadmap and Joint Commitment Januari 28, 2022
    KUALA LUMPUR, Malaysia, Jan. 28, 2022 /PRNewswire/ -- Having adopted the Consolidated Strategy on the Fourth Industrial Revolution (4IR) at the 38th ASEAN Summit in October last year, ASEAN organised a socialisation webinar for the Strategy, themed: 'Embracing the 4IR: Outlook, Strategies, and Plans for ASEAN' . The Strategy, as revealed at the webinar, was […]
  • "Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches Januari 28, 2022
    TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day on January 30. The international campaign includes awareness-raising events and outreach to governments, and is being publicized via newspapers, television, radio and […]
  • LambdaTest Announces Integration with Datadog Januari 28, 2022
    This integration will enable better monitoring and collaboration in the DevOps teams SAN FRANCISCO, Jan. 28, 2022 /PRNewswire/ -- LambdaTest, a leading test execution platform, announced an integration with Datadog, Inc. (NASDAQ: DDOG), the monitoring and security platform for cloud applications. This integration is now available in the Datadog Marketplace. With the LambdaTest and Datadog […]
  • CooTek's Love Fantasy Topped Most Downloaded iOS Chinese Overseas Games Chart for December 2021, Surpassing PUBG And Genshin Impact Januari 28, 2022
    SHANGHAI, Jan. 28, 2022 /PRNewswire/ -- Love Fantasy, a mobile game invested by CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), has topped the list of Most Downloaded iOS Chinese Overseas Games in December 2021, with 2.5 million total downloads and a 216.5% month-on-month increase. On Google Play, it ranked in the second place […]
  • ATFX is the Most Trusted Brand in the Forex Industry Januari 28, 2022
    HONG KONG, Jan. 28, 2022 /PRNewswire/ -- Recently, The Business Fame awarded the title of Most Trusted Brand 2021 to ATFX, recognizing its innovative trading model, strict capital supervision, and excellent user experience. As the COVID-19 virus continues to rage worldwide, no industry is immune to it. Against this background, the financial sector keeps changing the […]
  • Electrolux Q4 2021 Interim report: Ending a record year with solid execution in Q4 Januari 28, 2022
    STOCKHOLM, Jan. 28, 2022 /PRNewswire/ -- Highlights of the full-year of 2021 In full-year 2021, strong price execution and attractive product and brand offering resulted in record net sales of SEK 125,631m (115,960), operating income excl. non-recurring items of SEK 7,528m (5,778), and operating margin excl. non-recurring items of 6.0% (5.0). Income for the period […]
  • Getinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow" Januari 28, 2022
    GOTHENBURG, Sweden, Jan. 28, 2022 /PRNewswire/ -- "The organic order intake increased 6.4% in the fourth quarter following growth in all business areas and regions", says Mattias Perjos, President & CEO at Getinge. "Excluding currency effects, our order bookings are more than 20% larger compared with one year ago." As expected, Getinge's net sales declined […]
  • Discover the hidden treasures of Japan: a spectacular cultural legacy, in unity with nature Januari 28, 2022
    TOKYO, Jan. 28, 2022 /PRNewswire/ -- Last November, the Agency for Cultural Affairs, in cooperation with the Japan National Tourism Organization, revealed additional special content featuring exclusive destinations for its Japan Heritage website. The content helps provide a more relaxed travel experience; soaking in the local atmosphere and taking a deep dive into Japan Heritage's […]
  • Richard Attias & Associates (RA&A) Announces 2022 Global Strategy & New Leadership Team Januari 28, 2022
    - Richard Attias & Associates, one of the world's leading strategic communications firms and platform curators, has reorganized its offerings around five core expertise to support policymakers, governments, corporations and institutions during this time of unprecedented change. - RA&A's transformation will strengthen its ability to drive impact through bold diplomacy strategies and pioneering live and virtual […]
  • GWM Strategic Model HAVAL H6 has been Selling Well Globally for Ten Years Januari 28, 2022
    BAODING, China, Jan. 28, 2022 /PRNewswire/ -- According to GWM's official data, the global sales of HAVAL H6 reached 370,437 units in 2021, which represents a new milestone for the company sales performance. HAVAL H6 ranked 7th in the list of the world's best-selling SUVs in 2021 released by Focus2Move, an internationally renowned market research […]
  • VIISA announced its investment in SHub - a Vietnamese edTech startup Januari 28, 2022
    HO CHI MINH CITY, Vietnam, Jan. 28, 2022 /PRNewswire/ -- VIISA, a Vietnamese Venture Capital firm that invests in early-stage startups, announced its latest investment in a EdTech startup named SHub, an online teaching, learning solutions for classroom management. Team SHub "Besides the online training solution that is close to traditional training and easy to […]
Share this:
Share
Translate »
Creative Commons License
Except where otherwise noted, © GoInternationalGroup.com on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.